Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0198 | 0.2547 | 0.3708 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0223 | 0.3131 | 0.4188 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.018 | 0.2149 | 0.2574 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0415 | 0.7476 | 1 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0259 | 0.3948 | 0.528 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0295 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0227 | 0.3214 | 0.4299 |
Mycobacterium ulcerans | thioesterase TesA | 0.0231 | 0.3311 | 0.443 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0223 | 0.3131 | 0.4155 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0112 | 0.061 | 0.0817 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0278 | 0.4361 | 0.5834 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.05 | 0.9416 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0223 | 0.3131 | 0.4188 |
Mycobacterium ulcerans | thioesterase | 0.0231 | 0.3311 | 0.443 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0278 | 0.4361 | 0.4361 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0158 | 0.1644 | 0.2199 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0184 | 0.2228 | 0.2981 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0087 | 0.0042 | 0.0056 |
Loa Loa (eye worm) | fatty acid synthase | 0.0274 | 0.4277 | 0.4318 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0295 | 0.4752 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0278 | 0.4361 | 0.581 |
Mycobacterium ulcerans | polyketide synthase | 0.0278 | 0.4361 | 0.5834 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0295 | 0.4752 | 0.6337 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0278 | 0.4361 | 0.5834 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0269 | 0.4168 | 0.5576 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0415 | 0.7476 | 1 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0269 | 0.4168 | 0.5576 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0184 | 0.2228 | 0.2981 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0295 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0415 | 0.7476 | 1 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0259 | 0.3948 | 0.3889 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0295 | 0.4752 | 0.6357 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0278 | 0.4361 | 0.5834 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0278 | 0.4361 | 0.5834 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0231 | 0.3311 | 0.4398 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0278 | 0.4361 | 0.581 |
Onchocerca volvulus | 0.0483 | 0.9025 | 0.9285 | |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0095 | 0.0229 | 0.0306 |
Mycobacterium ulcerans | polyketide synthase | 0.0295 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0295 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0231 | 0.3311 | 0.443 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0199 | 0.2588 | 0.3461 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0278 | 0.4361 | 0.5834 |
Brugia malayi | AMP-binding enzyme family protein | 0.0259 | 0.3948 | 0.3948 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0295 | 0.4752 | 0.6337 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0415 | 0.7476 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0278 | 0.4361 | 0.5834 |
Loa Loa (eye worm) | hypothetical protein | 0.0466 | 0.8643 | 1 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0087 | 0.0042 | 0.0056 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0184 | 0.2228 | 0.2941 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.1592 | 0.0823 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0295 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0278 | 0.4361 | 0.5834 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0295 | 0.4752 | 0.6337 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of Nrf2 Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.